Thomas V. Bilfinger - Concepedia

Author

Thomas V. Bilfinger

Also Known As

Anelechi Anyanwu, Jae Won Kim, Lauren Taylor, Matthias Corbascio, T BILFINGER, T Bilfinger, T V Bilfinger, T. Bilfinger, T. V. Bilfinger, T.V Bilfinger

284

Publications

7.1K

Citations

H-Index

179

Concepts

All Affiliations

Stony Brook University SUNY Old Westbury State University of New York Stony Brook University Hospital MedStar Health

About

Thomas V. Bilfinger is an author at Stony Brook University specializing in medicine, pharmacology, and anesthesiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	79	3.9K
2	Health Sciences	16	17	848
3	Public Health	11	12	1.3K
4	Engineering	5	5	136
5	Natural Sciences	1	1	12

Thomas V. Bilfinger

126

Publications

Citations

H-Index

Page 1

	Year	Citations
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys, The Lancet Percutaneous Coronary InterventionControlled Syntax TrialEndovascular TechniqueCardiovascular DiseaseHealth Policy	2019	618
Presence of the μ3 Opiate Receptor in Endothelial Cells George B. Stefano, Alan Hartman, Thomas V. Bilfinger, Journal of Biological Chemistry	1995	277
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis Ron Waksman, Toby Rogers, Rebecca Torguson, Journal of the American College of Cardiology Cardiovascular DiseaseVascular SurgeryLow-risk PatientsValve DiseaseValvular Heart Disease	2018	227
Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. George B. Stefano, A. Digenis, S. Spector, Proceedings of the National Academy of Sciences Opiate-like SubstancesImmunologyPharmacotherapyOpiate ReceptorExperimental Pharmacology	1993	211
Comparison of Survival after Sublobar Resections and Ablative Therapies for Stage I Non−Small Cell Lung Cancer Alla Zemlyak, William H. Moore, Thomas V. Bilfinger Journal of the American College of Surgeons	2010	183
Cell-Surface Estrogen Receptors Mediate Calcium-Dependent Nitric Oxide Release in Human Endothelia George B. Stefano, Vincent Prévot, Jean‐Claude Beauvillain, Circulation	2000	170
Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide Harold I. Magazine, Y Liu, Thomas V. Bilfinger, The Journal of Immunology	1996	160
Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. Maynard H. Makman, Thomas V. Bilfinger, George B. Stefano The Journal of Immunology	1995	130
Five-Year Survival after Cryoablation of Stage I Non–Small Cell Lung Cancer in Medically Inoperable Patients William H. Moore, Ronak Talati, Priya Bhattacharji, Journal of Vascular and Interventional Radiology OncologyFive-year SurvivalMedicineMedically Inoperable PatientsBronchial Neoplasm	2015	125
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis Ron Waksman, Paige Craig, Rebecca Torguson, JACC: Cardiovascular Interventions Cardiovascular DiseaseLow-risk PatientsValve DiseaseValvular Heart DiseasePublic Health	2020	124

Page 1